Clinical Trials
Neurology Clinical Trials
- Multi-Center Trial to Evaluate Home-Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old
- Clinical Trial Ceftriaxone in subjects with ALS
- Colonoscopic Screening for Autonomic Pathology in Parkinson Disease
- Cooperative Huntington's Observational Research Trial (COHORT)
- Genetic and Environmental Risk Factors for PSP
- Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA)
- Insulin Resistance Intervention after Stroke or TIA (IRIS)
- Neuroimaging to Elucidate the Mechanism of Tic Resolution in Tourette Syndrome
- Parkinson's Genetic Risk (PaGeR) Study
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
- Stroke Hyperglycemia insulin Network Efforts (SHINE)
- A Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivery in Participants with Mild to Moderate Alzheimer's Disease
- Phase II safety and efficacy study of Cogane in early Parkinson's disease
- A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727- 301 or in Study ELN115727-302
- IGIV-A Randomized, Double-Blind, Placebo-Controlled, Two Dose-Arm, Parallel Study of the IGIV - Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-to-Moderate Alzheimer's Disease
- A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease
Social Media
Copyright © 2011 University of Utah Health Care